109 related articles for article (PubMed ID: 17641509)
1. Introducing new technologies into the clinic.
Vijayakumar S; Narayan S; Yang CC; Boerner P; Jacob R; Mathai M; Harse R; Purdy J
Front Radiat Ther Oncol; 2007; 40():180-192. PubMed ID: 17641509
[TBL] [Abstract][Full Text] [Related]
2. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN
Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276
[TBL] [Abstract][Full Text] [Related]
3. A dosimetric analysis comparing treatment of low-risk prostate cancer with TomoTherapy versus static field intensity modulated radiation therapy.
Shah AP; Chen SS; Strauss JB; Kirk MC; Coleman JL; Coon AB; Miller C; Dickler A
Am J Clin Oncol; 2009 Oct; 32(5):460-6. PubMed ID: 19564784
[TBL] [Abstract][Full Text] [Related]
4. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
5. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer.
Liu YM; Shiau CY; Lee ML; Huang PI; Hsieh CM; Chen PH; Lin YH; Wang LW; Yen SH
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1113-23. PubMed ID: 17197126
[TBL] [Abstract][Full Text] [Related]
6. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
7. Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer.
Pearlstein KA; Chen RC
Semin Radiat Oncol; 2013 Jul; 23(3):182-90. PubMed ID: 23763884
[TBL] [Abstract][Full Text] [Related]
8. Potential benefits of dosimetric VMAT tracking verified with 3D film measurements.
Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2016 May; 43(5):2162. PubMed ID: 27147328
[TBL] [Abstract][Full Text] [Related]
9. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
Coleman L; Skourou C
Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
[TBL] [Abstract][Full Text] [Related]
11. Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy.
Senthi S; Gill SS; Haworth A; Kron T; Cramb J; Rolfo A; Thomas J; Duchesne GM; Hamilton CH; Joon DL; Bowden P; Foroudi F
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):998-1005. PubMed ID: 21310548
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of the benefit of fiducial image-guidance for prostate cancer intensity modulated radiation therapy using daily dose volume histogram analysis.
Kasaova L; Sirak I; Jansa J; Paluska P; Petera J
Technol Cancer Res Treat; 2014 Feb; 13(1):47-55. PubMed ID: 23819493
[TBL] [Abstract][Full Text] [Related]
13. [A microcost analysis of radiation therapy of localized prostate cancer].
Zemplényi AT; Mangel L; Kaló Z; Endrei D; Boncz I
Orv Hetil; 2016 Mar; 157(12):461-8. PubMed ID: 26971646
[TBL] [Abstract][Full Text] [Related]
14. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
[TBL] [Abstract][Full Text] [Related]
15. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M
Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403
[TBL] [Abstract][Full Text] [Related]
16. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.
Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C
BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656
[TBL] [Abstract][Full Text] [Related]
17. Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study.
Cassidy RJ; Yang X; Liu T; Thomas M; Nour SG; Jani AB
Med Dosim; 2016 Winter; 41(4):339-343. PubMed ID: 27745996
[TBL] [Abstract][Full Text] [Related]
18. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
20. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]